AbstractUnderstanding the dose-response relation between a continuous treatment and the outcome for an individual can greatly drive decision-making, particularly in areas like personalized drug dosing and personalized healthcare interventions. Point estimates are often insufficient in these high-risk environments, highlighting the need for
→